Verification of Inter-laboratorial Genotyping Consistency in the Molecular Diagnosis of Polyglutamine Spinocerebellar Ataxias

• Published in: Journal of molecular neuroscience Vol. 58; no. 1; pp. 83 - 87
• Main Authors: Ramos, Amanda, Raposo, Mafalda, Milà, Montserrat, Bettencourt, Conceição, Houlden, Henry, Cisneros, Bulmaro, Magaña, Jonathan J., Bettencourt, Bruno Filipe, Bruges-Armas, Jácome, Santos, Cristina, Lima, Manuela
• Format: Journal Article
• Language: English
• Published: New York Springer US 2016; Springer Nature B.V
• Subjects: Ataxins - genetics; Automation; Biology; Biomedical and Life Sciences; Biomedicine; Capillary electrophoresis; Cell Biology; Collaboration; Genetic testing; Genetic Testing - standards; Genetics; Genotype; Genotyping Techniques - standards; Humans; Laboratories; Neurochemistry; Neurology; Neurosciences; Observer Variation; Peptides - genetics; Polymers; Proteomics; Spinocerebellar Ataxias - genetics; Trinucleotide Repeat Expansion - genetics; Mexico; Azores; Portugal; Terceira; Spain; SCA; Molecular testing; Fragment analysis; Neurodegenerative disorders
• DOI: 10.1007/s12031-015-0646-y
• ISSN: 0895-8696

The polyglutamine spinocerebellar ataxias (SCAs) constitute a clinically and genetically heterogeneous group of rare late-onset neurodegenerative disorders, caused by CAG expansions in the coding region of the respective genes. Given their considerable clinical overlapping, differential diagnosis relies on molecular testing. Laboratory best practice guidelines for molecular genetic testing of the SCAs were released in 2010 by the European Molecular Genetics Quality Network, following the recognition of gross genotyping errors by some diagnostic laboratories. The main goal of this study was to verify the existence of inter-laboratorial consistency comparing genotypes for SCA1, SCA2, SCA3, SCA6 and SCA7 obtained by independent diagnostic laboratories. The individual impact of different methodological issues on the genotype for the several SCAs was also analysed. Four international collaborative diagnostic laboratories provided 79 samples and the respective SCA genotypes. Samples were genotyped in-house for all SCAs using an independent methodology; comparison of the allele size obtained with the one provided by the collaborative laboratories was performed. Globally, no significant differences were identified, a result which could be reflecting the fulfilment of recommendations for the molecular testing of SCAs and demonstrating an improvement in genotyping accuracy.